Research Finds Loud Noises Can Lead to Fluid Buildup in the Ear

According to the World Health Organization, over 1 billion young adults are at risk of permanent, avoidable hearing loss due to unsafe listening practices. This includes listening through headphones at a high volume for prolonged amounts of time and attending concerts and sporting events at Hertz Arena without wearing hearing protection.

While it’s well established that loud sounds cause hearing loss, the mechanism behind this phenomenon was not well understood. Recent research has uncovered that loud noises can actually lead to fluid buildup in the ear, contributing to hearing loss.

About the Study

The study, entitled “Endolymphatic Hydrops Is a Marker of Synaptopathy Following Traumatic Noise Exposure,” was published in the journal Frontiers in Cell and Developmental Biology in November of 2021. The research team includes students at the Keck School of Medicine of the University of Southern California.

They found that loud sounds not only cause a loss of auditory nerve cells in the inner ear, but also that exposure to them is associated with a condition known as endolymphatic hydrops, which is a buildup of fluid in the inner ear.

Additionally, they uncovered that treating this fluid buildup with a saline solution lessened nerve damage.

Study Implications

Loss of nerve cells in the inner ear is sometimes known as “hidden hearing loss” since tests often cannot detect the damage. However, scanning for fluid buildup can help experts diagnose impending nerve damage and take steps to prevent it.

According to lead study author John Oghalai, M.D., “First, if human ears exposed to loud noise, such as a siren or airbag deployment, can be scanned for a level of fluid buildup – and this technology is already being tested out – medical professionals may have a way of diagnosing impending nerve damage. Secondly, if the scan discovered fluid buildup, people could be treated with hypertonic saline and possibly save their hearing.”

In addition, this research has important implications for the research and treatment of Meniere’s disease, a condition that causes episodes of hearing loss, tinnitus (ringing in the ear) and vertigo (spinning sensation) that is thought to be caused by a buildup of fluid in the ear.

For more information or to schedule an appointment for a hearing test, call Center For Hearing today.

< Older Post

Newer Post >

The Future of Hearing Devices: Deep Neural Networks & Artificial Intelligence

February 14, 2025

Hearing technology has come a long way over the years; however, one aspect of hearing loss that many hearing aids have difficulty addressing is trouble understanding speech in noise. Fortunately, some of today’s state-of-the-art devices can solve this problem utilizing deep neural networks (DNN) and artificial intelligence (AI). Sensorineural hearing loss causes difficulty understanding speech in background noise. This type of hearing loss is caused by damage to the hair cells of the inner ear that convert soundwaves into electrical energy, which are then interpreted by the brain. This causes the quality and quantity of the signal sent from the ears to the brain to diminish over time, resulting in the brain expending more energy and effort to make sense of it. DNNs may help improve the transmission of the neural code, making hearing easier on the brain. [1] It’s important to know what DNNs are to understand how they can help. DNNs are a subset of AI. They rapidly analyze large data sets so that they can teach hearing aids and other technological devices how to respond to data like a human would, all while verifying accuracy and making corrections. DNNs are beneficial in hearing technology because they can help with speech enhancement. DNNs can be applied as “time-frequency masks,” meaning select sounds—like speech—are allowed while other sounds are suppressed. DNNs can also identify and separate multiple voices, selecting a primary voice to emphasize and secondary voices to suppress. This feature can help hearing device wearers in a variety of settings. For example, at a restaurant or party, the hearing device can emphasize a conversation partner, allow other nearby voices at a reduced volume and suppress background noises such as dishes clinking. Schedule an appointment to talk to Center for Hearing about our vast state-of-the-art hearing solutions today— (239) 434-0086. [1] Published by Douglas L. Beck. (2021, January 15). Deep neural networks in hearing devices. Retrieved April 2, 2021 from https://www.hearingreview.com/hearing-products/hearing-aids/deep-neural-networks

Startup Aims to Develop the First Gene Therapy for Hearing Loss

February 14, 2025

A Boston biotech startup is attempting to develop the first gene therapy treatment for hearing loss. If successful, it promises to offer new hope to the estimated 300,000 Americans who suffer from gene-based hearing loss—a number that includes more than 4,000 newborns. The timing may not be ideal, but biotech companies have been largely immune from the effects of the COVID-19 pandemic and ensuing recession. Developing new drugs takes years, so these companies are better able to weather storms. And the efforts of biotechnology companies that are focusing on tools to prevent and treat potentially fatal health threats has resulted in soaring stock values for many of these companies, even in the face of the current crisis. Akouos, the Boston startup, was founded in 2016. Its goal is to develop the first gene therapy to treat hearing loss and is targeting a specific form of deafness that results from mutations in a single gene. They are experimenting with adeno-associated viruses, using them as vectors to deliver DNA that encodes a functioning gene in certain target cells. Around 7,000 people are afflicted with this type of genetic hearing loss. Adeno-associated viruses are considered viable candidates because they don’t usually cause disease and can be customized to treat a variety of genetic conditions. The company has partnered with two influential organizations: Massachusetts Eye and Ear and Lonza, a Swiss manufacturing company that holds contracts with various pharmaceutical makers. Manny Simons, Akouos’ co-founder and chief executive, holds a degree in neuroscience from Harvard College, a Ph.D. in biomedical engineering from the Massachusetts Institute of Technology, and an MBA from Harvard Business School. His desire to help those with hearing loss stems from his passion for playing the piano. “It’s easy to take hearing for granted,” said in a Boston Globe interview. “Maybe because music has been important to me, it’s something that I take a little less for granted.” [1] [1] Saltzman, J. (2020, June 22). Akouos, a startup developing a gene therapy for hearing loss, raises IPO value to $125 million - The Boston Globe. Retrieved June 30, 2020, from https://www.bostonglobe.com/2020/06/22/business/ipo-upped-akouos-boston-startup-working-gene-therapy-hearing-loss/